Investor mix
15 investors on record; lead investors include Toyo Ink Group, Miyako Capital, Sojitz, Konishiyasu.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 33% |
| Accelerator & incubator | 1 | 7% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 8 | 53% |
Developer of therapeutic vaccines for the treatment of cancer, infectious and CNS disease
15 investors on record; lead investors include Toyo Ink Group, Miyako Capital, Sojitz, Konishiyasu.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 33% |
| Accelerator & incubator | 1 | 7% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 8 | 53% |